Baraclude

Baraclude

Marketed minn: Bristol-Myers Squibb Pharma EEIG
Ingredjent attiv: Entecavir

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bemfola

Bemfola

Marketed minn: Gedeon Richter Plc.
Ingredjent attiv: follitropin alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Benefix

Benefix

Marketed minn: Pfizer Europe MA EEIG
Ingredjent attiv: Nonacog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Benepali

Benepali

Marketed minn: Samsung Bioepis NL B.V.
Ingredjent attiv: etanercept

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Benlysta

Benlysta

Marketed minn: GlaxoSmithKline (Ireland) Limited
Ingredjent attiv: belimumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Beromun

Beromun

Marketed minn: Belpharma s.a.
Ingredjent attiv: tasonermin

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Betaferon

Betaferon

Marketed minn: Bayer AG 
Ingredjent attiv: interferon beta-1b

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Betmiga

Betmiga

Marketed minn: Astellas Pharma Europe B.V.
Ingredjent attiv: Mirabegron

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bexsero

Bexsero

Marketed minn: GSK Vaccines S.r.l.
Ingredjent attiv: - membrana ta ' barra nfafet minn neisseria meningitidis tal-grupp b (razza nz 98/254), rikombinanti Neisseria meningitidis tal-grupp B fHbp proteina tal-fużjoni, rikombinanti Neisseria meningitidis tal-grupp B NadA proteina rikombinanti Neisseria meningitidis tal-grupp B NHBA proteina tal-fużjoni

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bindren

Bindren

Marketed minn: Mitsubishi Pharma Europe Ltd
Ingredjent attiv: colestilan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Binocrit

Binocrit

Marketed minn: Sandoz GmbH
Ingredjent attiv: epoetin alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Biograstim

Biograstim

Marketed minn: AbZ-Pharma GmbH
Ingredjent attiv: filgrastim

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Biopoin

Biopoin

Marketed minn: Teva GmbH
Ingredjent attiv: epoetin theta

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Biresp Spiromax

Biresp Spiromax

Marketed minn: Teva Pharma B.V.
Ingredjent attiv: budesonide, formoterol fumarate dihydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Blincyto

Blincyto

Marketed minn: Amgen Europe B.V.
Ingredjent attiv: blinatumomab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bondenza (previously Ibandronic Acid Roche)

Bondenza (previously Ibandronic Acid Roche)

Marketed minn: Roche Registration Ltd.
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bondronat

Bondronat

Marketed minn: Atnahs Pharma Netherlands B.V.
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bonviva

Bonviva

Marketed minn: Atnahs Pharma UK Limited
Ingredjent attiv: ibandronic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bortezomib Accord

Bortezomib Accord

Marketed minn: Accord Healthcare S.L.U.
Ingredjent attiv: bortezomib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bortezomib Hospira

Bortezomib Hospira

Marketed minn: Pfizer Europe MA EEIG
Ingredjent attiv: bortezomib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bortezomib Sun

Bortezomib Sun

Marketed minn: SUN Pharmaceutical Industries (Europe) B.V.
Ingredjent attiv: bortezomib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bosulif

Bosulif

Marketed minn: Pfizer Europe MA EEIG
Ingredjent attiv: bosutinib (bħala monoidrat)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bretaris Genuair

Bretaris Genuair

Marketed minn: AstraZeneca AB
Ingredjent attiv: bromur ta 'aclidinium, mikronizzat

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bridion

Bridion

Marketed minn: Merck Sharp & Dohme B.V.
Ingredjent attiv: sugammadex

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Brilique

Brilique

Marketed minn: AstraZeneca AB
Ingredjent attiv: ticagrelor

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Brimica Genuair

Brimica Genuair

Marketed minn: AstraZeneca AB
Ingredjent attiv: aclidinium, formoterol fumarate dihydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Brinavess

Brinavess

Marketed minn: Cardiome UK Limited
Ingredjent attiv: Vernakalant hydrochloride

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Brintellix

Brintellix

Marketed minn: H. Lundbeck A/S
Ingredjent attiv: Vortioxetine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Briviact (in Italy: Nubriveo)

Briviact (in Italy: Nubriveo)

Marketed minn: UCB Pharma SA
Ingredjent attiv: Brivaracetam

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Bronchitol

Bronchitol

Marketed minn: Pharmaxis Europe Limited
Ingredjent attiv: mannitol

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency